Haikou Huashilian Pharmaceutical Technology

Haikou Huashilian Pharmaceutical Technology is a pharmaceutical research and development company headquartered in Haikou, China. Established in 2010, the firm specializes in the development of high-end generic drugs and innovative small molecule therapeutics, with a particular emphasis on cardiovascular and metabolic health. The company provides a full suite of services including drug synthesis, formulation R&D, and bioequivalence testing, often operating as a technology partner for larger manufacturing firms. Huashilian is recognized for its expertise in the Consistency Evaluation of generic drugs in the Chinese market, particularly for anticoagulant medications like Rivaroxaban and Apixaban. Their business model focuses on technology transfer and collaborative development to bring high-quality affordable medicines to the healthcare system.